LawPlayer
My bookmarksSign up freeSign up free

Commission Implementing Regulation (EU) 2021/1280 CHAPTER IV — PREMISES AND EQUIPMENT

Article 9–Article 10 · 2 articles

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Requirements for premises and equipment

Article 9

Open ↗

1.   Premises and equipment shall be suitably located, designed, constructed and maintained to ensure: (a) appropriate operations, such as receiving, proper storage, picking, packing and dispatch; (b) protection from contamination, amongst other through narcotics, highly sensitising materials, materials of high pharmacological activity or toxicity; (c) proper distribution of active substances used as starting materials in veterinary medicinal products. 2.   There shall be sufficient space, lighting and ventilation to ensure required segregation, appropriate storage conditions and cleanliness. 3.   Monitoring devices that are necessary to guarantee the quality attributes of the active substances used as starting materials in veterinary medicinal products shall be subject to calibration against certified traceable standards, according to an approved schedule. 4.   Receiving and dispatch activities shall, if possible, be done in separate places. If that is not possible, those activities shall be conducted at separate times. 5.   Areas for receiving active substances used as starting materials in veterinary medicinal products shall protect deliveries from prevailing weather conditions during unloading. 6.   The reception area shall be separate from the storage area. 7.   Appropriate cleaning equipment and cleaning agents shall be chosen and used so as not to constitute a source of contamination. 8.   Premises shall be protected from the entry of birds, rodents, insects and other animals. A rodent and a pest control programme shall be implemented and maintained. Its effectiveness shall be monitored. 9.   Defective equipment shall not be used and shall either be removed or labelled as defective. Equipment shall be disposed of in such a way as to prevent any misuse. 10.   Segregated areas shall be provided for the storage of received, quarantined, rejected, recalled and returned active substances used as starting materials in veterinary medicinal products, including those with damaged packaging. 11.   Any system replacing physical segregation, as applicable, such as electronic segregation based on a computerised system, shall provide equivalent security and shall be subject to appropriate validation. 12.   Segregated areas and products shall be appropriately identified.

Access to premises

Article 10

Open ↗

Access shall be controlled and premises shall be suitably secured to prevent unauthorised access.

Back to Commission Implementing Regulation (EU) 2021/1280 — full text

Articles on this page are reproduced verbatim from official open data. See the attribution line.

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next